Underestimation of the effect of bleeding in clinical trials.
Stewart
Ralph A
RA
D054058:Acute Coronary Syndrome / Q000188:drug therapy* / Q000401:mortality; D017322:Clinical Trials, Phase II as Topic; D003627:Data Interpretation, Statistical; D006470:Hemorrhage / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D009025:Morpholines / Q000009:adverse effects*; D012107:Research Design; D000069552:Rivaroxaban; D013876:Thiophenes / Q000009:adverse effects*; D016896:Treatment Outcome; D055815:Young Adult
D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban